Event

Jorge Fernando. Maspero

MD
Fundación CIDEA

Barbara A. Knorr

MD
Novartis;Novartis Pharmaceuticals Corporation

Diego Ossa

MD
Novartis Pharma AG

Edna Cahill

MS
Novartis Pharmaceuticals Corporation

Leif Bjermer

MD, PhD
Lund University;Skåne University Hospital, Lund University

Edward M. Kerwin

phd
Clinical Research Institute;Clinical Research Institute of Southern Oregon, PC;Crisor, LLC c/o Clinical Research Institute of Southern Oregon, Inc.

David Lawrence

PhD
Novartis Pharma AG

Vishal Mishra

MBBS
Novartis Healthcare Pvt. Ltd

Pamela Cardenas

MS
Novartis Pharmaceuticals Corporation

Fevipiprant Efficacy in Improving Lung Function in Patients with Moderate Uncontrolled Asthma: Study Design of ZEAL 1 and ZEAL 2 Phase III Randomized Controlled Studies